Amazon is developing cancer vaccines in collaboration with the Fred Hutchinson Cancer Center, and it recently launched an FDA-approved clinical trial.
Amazon and Fred Hutchinson are looking to recruit 20 participants over the age of 18 for the early-stage, or phase 1, trial, according to a filing on clinicaltrials.gov, a database of clinical trials run by the National Library of Medicine. The goal is to develop “personalized vaccines” that can treat breast cancer and melanoma, a form of skin cancer, the filing states.
Fred Hutchinson is listed as a sponsor of the study, while Amazon is listed as a collaborator, according to the filing. News of the partnership was first reported by Business Insider. The study was first posted last October, and it began June 9. It’s expected to be complete by Nov. 1 of 2023.
Representatives from Amazon and Fred Hutchinson didn’t immediately respond to a request for comment.
Amazon has deepened its presence in the health care industry in recent years. The company in 2020 launched an online pharmacy, it has ramped up its telehealth service, called Amazon Care, and it has sought to develop at-home medical diagnostics.
A secretive research and development group inside Amazon, known as Grand Challenge, initially oversaw the cancer vaccine effort, according to Business Insider, which cited people familiar with the matter. It’s now under the purview of a cancer research team reporting to Amazon’s vice president of devices Robert Williams, Business Insider reported.
WATCH: Andy Jassy’s priority is to chart a next generation path for growth, says Madron’s McIlwain
